As a proof-of-concept, we used CRISPR/Cas9 genome editing to delete the mouse homologue of one of the AF risk loci on chromosome 6q22.31, around 680 Kbp downstream of Gja1 in mice (Fig. 5a). The gene discussed is GJA1; the disease is atrial fibrillation.